http://www.ekfdiagnostics.com/rss.aspxLatest Investor News From EKF Diagnostics(c) 2011, EKF Diagnostics . All rights reserved.5Update on the Disposal of International Brand Licensing AGhttp://www.ekfdiagnostics.com/InvestorStories.aspx?id=5011/05/2012 00:00:00Stanbio Laboratory announced today that the sales, marketing and service functions in the United States for its popular point-of-care HemoPoint® H2 hemoglobin system has been transitioned to Alere, Inc. http://www.ekfdiagnostics.com/InvestorStories.aspx?id=4925/04/2012 00:00:00EKF, the growing in-vitro diagnostics company, announces that today it has received notification of the following exercise of options today over Ordinary Shares of one pence each in the Company by Adam Reynolds and Paul Foulger all at an exercise price of 1 pence per Ordinary Share.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=4705/04/2012 00:00:00EKF Diagnostics Holdings plc, announces that it has been granted a patent in the People’s Republic of China for its Hemo Control microcuvettes, branded as NXT microcuvettes.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=4805/04/2012 00:00:00Notification of major interest in shareshttp://www.ekfdiagnostics.com/InvestorStories.aspx?id=4604/04/2012 00:00:00EKF Diagnostics Holdings plc, the growing in-vitro diagnostics company, announces that it has sold its Swiss subsidiary, International Brand Licensing AG for a cash consideration of £50,000, payable over a 2 year period. http://www.ekfdiagnostics.com/InvestorStories.aspx?id=4527/03/2012 00:00:00EKF Diagnostics Holdings plc, the growing in-vitro diagnostics company, announces its audited final results for the year ended 31 December 2011, a year of continued progress.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=4421/03/2012 00:00:00EKF to announce final results on 21 March 2012.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=4316/03/2012 00:00:00Acquisition or disposal of voting rights.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=4230/01/2012 00:00:00EKF Trading update.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=4119/01/2012 00:00:00EKF Diagnostics has been awarded a contract in Mexico for 3,500 HemoPoint H2 haemoglobin testing devices.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=2402/12/2011 00:00:00EKF grows its market share in the USA haemoglobin testing market. http://www.ekfdiagnostics.com/InvestorStories.aspx?id=2229/11/2011 00:00:00Acquisition or disposal of voting rights.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=2021/10/2011 00:00:00Acquisition or disposal of voting rights.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=2121/10/2011 00:00:00Acquisition or disposal of voting rights.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=1912/10/2011 00:00:00Acquisition or disposal of voting rights.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=1807/10/2011 00:00:00Acquisition or disposal of voting rights.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=1530/09/2011 00:00:00EKF Diagnostics announces the appointment of Richard Evans to the Board as Finance Director, with immediate effect. http://www.ekfdiagnostics.com/InvestorStories.aspx?id=1628/09/2011 00:00:00EKF Diagnostics Holdings plc announces its unaudited interim results for the six month period ended 30 June 2011, a period of transition, investment and progression.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=1728/09/2011 00:00:00EKF Diagnostics Holdings plc announces the appointment of Collins Stewart Europe Limited as its Nominated Adviser and Broker, with immediate effect.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=1427/09/2011 00:00:00EKF Diagnostics Holdings plc will announce its interim results for the six month period ended 30 June 2011 on Wednesday 28 September 2011.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=1323/09/2011 00:00:00EKF Diagnostics Holdings plc announces: Exercise of Options, Extension of Option Exercise Period and Total Voting Rights.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=1229/06/2011 00:00:00EKF Diagnostics Holdings plc announces that at the General Meeting held earlier today all resolutions were duly passed.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=1015/06/2011 00:00:00EKF Diagnostics Holdings plc confirms that the Annual Report and Accounts for the year ended 31 December 2010, the Notice of the Annual General Meeting and a Form of Proxy were posted to shareholders on 10 June 2011.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=813/06/2011 00:00:00Report and accounts for year ending 31st December 2010.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=913/06/2011 00:00:00EKF Diagnostics Holdings plc announces its interim results for the six month period ended 30 June 2010.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=727/05/2011 00:00:00International Brand Licensing plc is pleased to announce that at the General Meeting held earlier today all resolutions were duly passed. http://www.ekfdiagnostics.com/InvestorStories.aspx?id=527/05/2011 00:00:00Preliminary unaudited financial statements for the year ended 31 December 2010.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=123/05/2011 00:00:00Following the exercise of options by @miral BV, the Company has allotted 650,000 new ordinary shares of 1p each.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=310/03/2011 00:00:00Identity of the issuer or the underlying issuer of existing shares.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=4009/12/2010 00:00:00EKF Diagnostics Holdings plc, which has recently refocused on the in-vitro diagnostic devices market, announces that the German Federal Court of Justice has issued a trial decision on 25 November 2010 following an appeal by Hemocue on an invalidation action by EKF-diagnostic GmbH against Hemocue's European patent in relation to the protection in Germany.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=3929/11/2010 00:00:00EKF Diagnostics Holdings plc, which has recently refocused on the in-vitro diagnostic devices market, announces it has entered into a deed of variation to amend the sale and purchase agreement relating to the acquisition of the entire issued share capital of Quotient Diagnostics Limited.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=3805/11/2010 00:00:00EKF Diagnostics Holdings plc, which has recently refocused on the in-vitro diagnostic devices market, announces that it has today completed the acquisition of the entire issued share capital of Quotient Diagnostics Limited. http://www.ekfdiagnostics.com/InvestorStories.aspx?id=3704/10/2010 00:00:00EKF Diagnostics Holdings plc, the AIM listed point-of-care diagnostics business, announces that it has acquired the entire issued share capital of Argutus Medical Limited.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=3602/10/2010 00:00:00Acquisition of Quotient Diagnostics Limited – SPA signed EKF Diagnostics Holdings plc, which has recently refocused on the in-vitro diagnostic devices market, announces it has entered into an agreement to acquire the entire issued share capital of Quotient Diagnostics Limited.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=3501/10/2010 00:00:00Order for over 3,000 Hemo Control analysers, cuvettes and accessories.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=3224/09/2010 00:00:00The Board recognises the importance of incentivising and rewarding the performance of its key executives and recently tasked the remuneration committee to recommend to the Board an appropriate long term incentive plan for its senior executives.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=3324/09/2010 00:00:00EKF Diagnostics Holdings plc, which has recently refocused on the in-vitro diagnostic devices market, announces that it proposes to acquire the entire issue share capital of Quotient Diagnostics Limited.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=3123/09/2010 00:00:00In accordance with the Financial Services Authority's Disclosure and Transparency Rules, EKF advises that it has a single class of shares in issue which are admitted to trading on AIM. http://www.ekfdiagnostics.com/InvestorStories.aspx?id=3030/07/2010 00:00:00EKF Diagnostics Holdings plc, which has recently refocused on the in-vitro diagnostic devices market, announces that David Evans (formerly Non-Executive Chairman) has today been appointed Executive Chairman of the Company.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=2927/07/2010 00:00:00EKF Diagnostics Holdings plc, which has recently refocused on the in-vitro diagnostic devices market, announces that it has sold the rights to the Admiral sports Brand in China, Hong Kong, Macau, Taiwan and Korea.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=2821/07/2010 00:00:00Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=2719/07/2010 00:00:00The Company announces that it has received notification that Hargreave Hale Limited has an indirect holding of 10,401,666 Ordinary Shares of 1p each representing approximately 7.30 per cent. of the voting rights in the Company.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=2509/07/2010 00:00:00International Brand Licensing plc is pleased to announce that at the General Meeting held earlier today all resolutions were duly passed.http://www.ekfdiagnostics.com/InvestorStories.aspx?id=602/07/2010 00:00:00